Modified antigens

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9200044
APP PUB NO 20150093414A1
SERIAL NO

14557929

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Modified Rv3616c proteins and their use as medicaments, particularly for the prevention of reactivation of tuberculosis.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • GLAXO GROUP LIMITED;SMITHKLINE BEECHAM BIOLOGICALS S.A.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Blais, Normand Laval, CA 30 174
Brown, James Collegeville, US 205 2256
Gelinas, Anne-Marie Laval, CA 2 9
Mettens, Pascal Rixensart, BE 23 66
Murphy, Dennis Collegeville, US 43 268

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 1, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00